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Abstract
Objectives
During surgeries that put the visual pathway at risk of injury, continuous monitoring of the vi-
sual function is desirable. However, the intraoperative monitoring of the visual evoked po-
tential (VEP) is not yet widely used. We evaluate here the clinical utility of intraoperative
VEP monitoring.
Methods
We analyzed retrospectively 46 consecutive surgeries in 2011-2013. High luminance stimu-
lating devices delivered flash stimuli on the closed eyelid during intravenous anesthesia.
We monitored VEP features N75 and P100 and took patients' preoperative and postopera-
tive visual function from patient charts. Postoperative ophthalmologic workup was per-
formed in 25 (54%) patients and preoperatively in 28 (61%) patients.
Results
VEP recordings were feasible in 62 of 85 eyes (73%) in 46 patients. All 23 eyes without
VEP had impaired vision. During surgery, VEPs remained stable throughout surgery in 50
eyes. In 44 of these, visual function did not deteriorate and three patients (6 eyes) devel-
oped hemianopia. VEP decreased transiently in 10 eyes and visual function of all was pre-
served. VEPs were lost permanently in 2 eyes in two patients without new postoperative
visual impairment.
Conclusions
Satisfactory intraoperative VEP monitoring was feasible in all patients except in those with
severe visual impairment. Preservation of VEPs predicted preserved visual function. During
resection of lesions in the visual cortex, VEP monitoring could not detect new major visual
field defects due to injury in the posterior visual pathway. Intraoperative VEPs were sensi-
tive enough to detect vascular damage during aneurysm clipping and mechanical
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manipulation of the anterior visual pathway in an early reversible stage. Intraoperative VEP
monitoring influenced surgical decisions in selected patients and proved to be a useful sup-
plement to the toolbox of intraoperative neurophysiological monitoring.
Introduction
Neurosurgery near the visual pathway carries a significant risk of visual impairment. In high
risk patients with lesions such as pituitary adenoma, craniopharyngioma or aneurysms, intrao-
perative monitoring for preservation of the visual function is desirable. However, the intrao-
perative monitoring of visual evoked potentials (VEPs) is not yet widely used and its usefulness
is debated in conflicting reports in the literature. First reports [1–3] described specific VEP fea-
tures which were monitored intraoperatively to improve the visual outcome. Further studies
[4–9], however, were more critical and considered intraoperative VEP to be unstable and vari-
able. Technical difficulties interfered with the feasibility. The correlation between VEP results
and visual outcome were disappointing. Sporadic favorable [10] reports were encountered by
contrary findings [11,12].
Only recently, high rates of feasibility were reported in a number of publications and stable
VEPs were associated with good postoperative visual function [13–16]. While evoked potential
recording and anesthesia protocols have remained unchanged, possibly the introduction of
high-luminance devices with supramaximal stimulation contributed to the success of VEP by
improving the constant stimulus delivery. We therefore introduced high-luminance VEP stim-
ulating devices in our clinic. In the current study we evaluate the feasibility and utility of the
intraoperative monitoring of the VEP.
Methods
Patients
We selected all consecutive patients who underwent cranial or transsphenoidal surgical proce-
dures where intraoperative VEP was monitored in our institution from November 2011 to De-
cember 2013. With this criterion we included 46 patients (mean age 50 y, range 2–81 y, 28
female, Table 1). We recorded bilateral VEP in all but some cases with unilateral indication, re-
sulting in VEP of 85 eyes. There were 42 patients with intracranial tumors, three with aneu-
rysms and one with an arachnoid cyst. All patients underwent pre- and postoperative
neurological examination of visual function. Ophthalmological documentation including
Goldmann kinetic perimetry was performed in 28 of 46 (61%) patients preoperatively and in
25 of 46 (54%) patients postoperatively.
Ethics statement
Retrospective collection of personal patient data and scientific workup was approved by the in-
stitutional ethics review board (Kantonale Ethikkommission KEK-ZH 2012–0212). The data
were collected retrospectively. Our institutional review board waived the need for written in-
formed consent from the participants (KEK-ZH 2012 0212, Kantonale Ethikkommission Zu-
rich). Patient information was anonymized and de-identified prior to analysis.
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Table 1. Patient characteristics.
Case
No.
Age
(yrs),
Sex
Pathology(location) Associated visual
disturbance
Number
of eyes
VEP
feasible
Preoperative visual
function
Postoperative
visual function
1 19, M medulloblastoma metastasis
(temporal and occipital lobe)
homonymous
hemianopia
2 yes normal unchanged TN
2 12, F pilocytic astrocytoma (right
optic nerve)
unilateral ﬁeld loss 2 yes visus impairment (rt) unchanged TN
3 45, F oligodendroglioma (parietal
lobe)
homonymous
hemianopia
2 yes normal homonymous
hemianopia
FN
4 67, M glioma (temporal and
occipital lobe)
homonymous
hemianopia
2 yes normal unchanged TN
5 50, F meningioma (optic chiasma) bitemporal
hemianopia
2 yes normal unchanged TN
6 59, F pituitary adenoma (optic
chiasma)
bitemporal
hemianopia
2 yes normal unchanged TN
7 54, F haemangiopericytom (right
optic nerve)
unilateral ﬁeld loss 2 yes normal unchanged TN
8 50, F glioblastoma (temporal and
occipital lobe)
homonymous
hemianopia
2 yes homonymous
quadrantanopsia
homonymous
hemianopia
FN
9 30,M pituitary adenoma (optic
chiasma)
bitemporal
hemianopia
2 yes normal unchanged TN
10 50, M chondrosarcoma (left optic
nerve)
unilateral ﬁeld loss 1 yes normal unchanged TN
11 54, F meningioma (right optic
nerve)
unilateral ﬁeld loss 2 yes visus impairment (rt) unchanged TN
12 62, F meningioma (left optic nerve) unilateral ﬁeld loss 2 yes normal unchanged TN
13 19, M pituitary adenoma (optic
chiasm)
bitemporal
hemianopia
2 yes normal unchanged TN
14 68, F meningioma (left optic nerve) unilateral ﬁeld loss 2 yes normal unchanged TN
15 60, F glioblastoma (parietal and
occipital lobe)
homonymous
hemianopia
2 yes normal homonymous
hemianopia
FN
16 25, M pituitary adenoma (left optic
nerve, optic chiasma)
bitemporal
hemianopia
2 yes visus impairment(lt) unchanged TN
17 75, M pituitary adenoma (optic
chiasma)
bitemporal
hemianopia
2 yes visus impairment (rt) and
temporal visual ﬁeld
defect (rt)
improved TN
18 59, F meningioma (right optic tract) homonymous
hemianopia
2 yes homonymous
quadrantanopsia
unchanged TN
19 14, F pituitary adenoma (optic
chiasma)
bitemporal
hemianopia
1 yes homonymous hemianopia unchanged TN
20 59, M metastasis (temporal and
occipital lobe)
homonymous
hemianopia
2 yes normal unchanged TN
21 49, F meningioma (optic chiasma) bitemporal
hemianopia
2 yes visus impairment and
bitemporal hemianopia
unchanged TN
22 58, F meningioma (left optic nerve) unilateral ﬁeld loss 2 yes normal unchanged TN
23 38, F craniopharyngioma (left optic
nerve, optic chiasma)
unilateral ﬁeld loss,
bitemporal
hemianopia
2 yes visus impairment (lt) and
bitemporal hemianopia
unchanged TN
24 57, M arachnoid cyst (left optic
nerve, optic chiasma)
unilateral ﬁeld loss,
bitemporal
hemianopia
2 yes visus impairment (lt) and
heteronymous
hemianopia
unchanged TN
25 34, M haemangioma cavernosum
(occipital lobe)
homonymous
hemianopia
2 yes normal unchanged TN
(Continued)
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Anesthesia management
Following the standard protocol for neurosurgical interventions, anesthesia was induced with
intravenous application of the sedative drug Propofol (4 to 8 mg/kg/min), the opioid analgesic
Remifentanil (1–2 μg/kg/min) and the skeletal muscle relaxant Atracurium (0.5 mg/kg). If
VEPs were monitored concurrently with other evoked potentials, Atracurium was omitted
after intubation because of its interference with electrophysiological monitoring and mapping
of motor function.
Table 1. (Continued)
Case
No.
Age
(yrs),
Sex
Pathology(location) Associated visual
disturbance
Number
of eyes
VEP
feasible
Preoperative visual
function
Postoperative
visual function
26 63, M pituitary adenoma (optic
chiasma)
bitemporal
hemianopia
2 yes bitemporal hemianopia complete
remission
TN
27 39, F craniopharyngioma (optic
chiasma)
bitemporal
hemianopia
1 yes temporal scotoma unchanged TN
28 47, F aneurysm (occipital lobe) homonymous
hemianopia
1 yes normal unchanged TN
29 55, F pituitary adenoma (optic
chiasma)
bitemporal
hemianopia
2 yes temporal hemianopia (lt) unchanged TN
30 35, F pilocytic astrocytoma (right
optic tract)
homonymous
hemianopia
2 yes homonymous hemianopia improved TN
31 65, F chondrosarcoma (left optic
nerve)
unilateral ﬁeld loss 2 yes left visus impairment unchanged TN
32 32, F meningioma (left optic nerve) unilateral ﬁeld loss 2 yes right visus impairment unchanged FP
33 36, M meningioma (left optic nerve) unilateral ﬁeld loss 2 yes quadrantanopsia (lt) unchanged TN
34 79, F meningioma (left optic nerve) unilateral ﬁeld loss 2 yes visus impairment (lt) unchanged TN
35 58, F aneurysm (right hemisphere) unilateral ﬁeld loss,
hemianopia
1 yes visus impairment (rt) unchanged FP
36 49, M pituitary adenoma (optic
chiasma, left optic tract)
bitemporal and
homonymous
hemianopia
2 yes homonymous hemianopia unchanged TN
37 81, F pituitary adenoma (optic
chiasma)
bitemporal
hemianopia
2 yes visus impairment unchanged TN
38 73, F B-Cell lymphoma (parietal
and occipital lobe)
homonymous
hemianopia
2 yes homonymous hemianopia improved TN
39 37, M pituitary adenoma (optic
chiasma)
bitemporal
hemianopia
2 no bitemporal hemianopia improved
40 38, F craniopharyngioma (optic
chiasma)
bitemporal
hemianopia
2 no visus impairment and
bitemporal hemianopia
improved
41 13, F astrocytoma (right optic
nerve, optic chiasma)
unilateral ﬁeld loss,
bitemporal
hemianopia
2 no visus impairment (rt) and
bitemporal hemianopia
unchanged
42 52, M pituitary adenoma (optic
chiasma)
bitemporal
hemianopia
2 no visus impairment and
bitemporal hemianopia
improved
43 76, F chordoma (optic chiasma) bitemporal
hemianopia
2 no visus impairment (lt) and
bitemporal hemianopia
unchanged
44 2, M pilomyxoid astrocytoma
(optic chiasma)
bitemporal
hemianopia
1 no visus impairment n/a
45 56, M meningioma (right optic
nerve)
unilateral ﬁeld loss 1 no amaurosis (lt), visual ﬁeld
defect (rt)
unchanged
46 17, M aneurysm (left hemisphere) unilateral ﬁeld loss,
hemianopia
2 no visus impairment and
quadratanopsia
Hemianopia
doi:10.1371/journal.pone.0120525.t001
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VEP stimulation device and parameters
After the induction of anesthesia, transparent eye patches were placed on the closed eyes. Then
the light-stimulating device was placed on the eyelids and covered with another transparent
eye patch. For the first 36 patients, we used devices from Unique Medical Co. Ltd, Tokyo [16]
with pulse length 40 ms. For the subsequent 10 Patients, we used stimulation devices from
Inomed (Inomed Medizintechnik GmbH, Germany, www.inomed.com, Fig. 1) with pulse
length 10 ms, which were also tested for safety in intraoperative 3 Tesla MRI [17]. The stimulus
frequency (1.1 Hz) was chosen to reduce line hum in the VEP. The red light-emitting diodes
provided (654 nm) illuminance up to 26000 Lux. While we set the illuminance to 20000 Lux in
our first surgeries ensure feasibility of the VEP, we also obtained reliable results with 1000 Lux
in some patients.
Recording electrode sites
Needle electrodes were inserted subcutaneously according to the international EEG 10–20-sys-
tem. The electrodes were placed on the bilateral preauricular point (A1, A2), the left and right
occiput (O1, O2), the occipital midline (Oz) and along the cortical midline (Cz, Fz). A1 and A2
were linked (A+) and served as recording reference.
VEP data acquisition and analysis
Flash VEP was recorded with the Inomed ISIS System. Recording was performed in a montage
of nine channels with the sites O1, O2, Oz against Fz, Cz and linked A1 and A2 (A+). We aver-
aged 100–200 flash stimulations to obtain one VEP waveform.
VEPs were band-passed at 5–100 Hz, displayed in a 500 ms-window with 10 μV/Division
and negative up. N75 and P100 peaks were selected in the latency range 50–150 ms after the
end of the stimulation pulse. The N75 amplitude was taken as the voltage difference between
the peaks N75 and P100. The P100 amplitude was taken as the difference between P100 and
the following negativity.
VEP monitoring was performed after completion of patient setup. At least two responses
were recorded to confirm the reproducibility of the VEP waveform, preferably before surgical
manipulation. When the surgical manipulation approached the area of interest, a baseline was
set as the control level for further monitoring.
Warning criterion
We applied a two-step warning criterion to take into account the individual spontaneous vari-
ability of VEP responses. First, a N75 amplitude decrease to less than 50% of the baseline was
taken as the warning criterion. Whenever VEP amplitude decreased below the warning criteri-
on, first technical failures were excluded and then anesthesia parameters were checked. If the
VEP change beyond the warning criterion could not be explained by a technical issue or the an-
esthesia regimen, a temporary warning was issued to the surgeon. In a second step, the succeed-
ing VEP was used to either confirm or reject the warning. If the warning criterion was not
reached, VEPs were referred to as “stable”.
Statistical analysis
Over the patient group, amplitude and latency of the N75 and P100 peaks were compared be-
tween eyes with preoperative intact visual function and eyes with preoperative
visual impairment.
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Statistical analyses were performed with IBM SPSS Statistics 22 (www.ibm.com) and custom
scripts in Matlab R2010a (www.Mathworks.com). For ratios, the 95% confidence intervals (CI)
were obtained on the basis of the binomial distribution. Distributions were compared by non-
parametric testing. Statistical significance was established as p<0.05.
We examined the correlation between intraoperative VEP features and postoperative visual
function. The outcomes of VEP and neurological examinations were dichotomized for statisti-
cal treatment in contingency tables with the chi² test. A contingency table contains the ele-
ments true positive (TP), true negative (TN), false positive (FP) and false negative (FN).
Derivations of these are the sensitivity or true positive rate TPR = TP/(TP+FN), the false posi-
tive rate FPR = FP/(FP+TN), the accuracy ACC = (TP+TN)/(TP+TN+FP+FN)), the specificity
1-FPR, the negative predictive value NPV = TN/(TN+FN), and the positive predictive value
PPV = TP/(TP+FP).
Fig 1. Light-stimulating device. Each device contains 19 red (654 nm) diodes that provide illuminance up to
25000 Lux.
doi:10.1371/journal.pone.0120525.g001
Table 2. Utility of VEP recording channels.
Channel Number of attempts Number of Success Success rate [%]
O1/A+ 73 42 58
Oz/A+ 74 53 72
O2/A+ 73 38 52
O1/Cz 63 31 49
Oz/Cz 61 40 66
O2/Cz 61 31 51
O1/Fz 33 16 48
Oz/Fz 49 26 53
O2/Fz 51 15 29
doi:10.1371/journal.pone.0120525.t002
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Results
Feasibility of intraoperative VEP
Intraoperative monitoring of VEP recordings was feasible in 62 of 85 eyes (73%, CI [62–82%])
and in 38 of 46 patients (83%, CI [69–92%]). There were no complications attributable to VEP
recording. Intraoperative VEP monitoring was not feasible in 23 eyes (17 patients). In 8 pa-
tients listed in Table 1, VEP could not be monitored from either eye. In the other 9 patients,
VEPs were monitored bilaterally but were only feasible in the eye with intact vision. The preop-
erative visual function of all these 23 eyes was impaired (12 eyes had a combination of visual
acuity impairment and visual field defect; 7 eyes had reduced visual acuity; 4 eyes had an im-
pairment of the visual field alone).
Recordings from Oz in the montage with reference A+ yielded the highest success rate (53/
74, 72%, Table 2). In general, the recordings with reference A+ provided the highest rate of fea-
sible VEP recordings (133/220, 60%).
Correlation of intraoperative VEP findings and postoperative visual
function
Correlation of VEP amplitude and visual outcome are shown in Tables 3 and 4. In 50 eyes with
stable VEP, visual function remained unchanged in 36 eyes, improved in 8 eyes, and 3 patients
(6 eyes) developed homonymous hemianopia. VEP decreased transiently in 10 eyes and visual
function of all these was preserved. VEPs were lost permanently in 2 eyes in two different pa-
tients without new postoperative visual impairment.
Three patients (6 eyes, patients 3, 8 and 15) showed homonymous hemianopia at the post-
operative neurological examination, which was confirmed ophthalmologically in two patients.
The intraoperative VEP in all patients had never reached the warning criterion (false-negative
FN).
In two eyes of two patients (patient 32 and 35), the postoperative neurological and ophthal-
mological examination revealed no new visual impairment. However, in these patients the ini-
tial reproducible VEPs were lost permanently during surgery (false-positive FP) for unknown
reasons. Since the dura was still closed at the time of VEP loss, no direct surgical maneuver
could have caused damage to the visual pathway and the VEP loss did not influence
surgical decisions.
Distribution of VEP latency and amplitude
The distribution of N75 latencies in all 62 eyes, where VEP was feasible, (Fig. 2) had a median
of 87 ms (range 51–142 ms). The spread may be due to effects of anesthesia. The median N75
Table 3. Relationship between VEP amplitude and visual outcome.
Intraoperative VEP amplitude Visual outcome
Unchanged 50 Unchanged 36
Improved 8
Visual ﬁeld defect 6
Transient loss 10 Unchanged 10
Permanent loss 2 Unchanged 2
VEP was feasible in N = 62 eyes.
doi:10.1371/journal.pone.0120525.t003
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amplitude was 2.8 μV (0.7–19.4 μV). The median amplitude and latency of P100 was 2.2 μV
(0.2–14.1 μV) and 106 ms (65–161 ms).
We divided the 62 eyes, where VEP was feasible, into the groups ‘vision intact’ (n1 = 33) and
‘vision impaired’ (n2 = 29) based on their preoperative visual function (Fig. 3). Between the
groups there was no statistically significant difference between latencies (N75 P = 0.61; P100 P =
0.53). In the ‘vision intact’ group, amplitudes were significantly higher both for N75 (P< 0.001)
and P100 (P< 0.001). VEPs with a large N75 amplitude (3. Quartile) were associated with a
high stability of the VEP waveform over the course of surgery (Fisher’s exact test P< 0.02).
False-positive transient VEP loss
In patient 27, shortly after the osteotomy, a generalized epileptic seizure occurred. During the
seizure, the VEP was lost. The seizure was immediately intercepted with sodium thiopental.
The swelling of the brain was controlled by Mannitol. After the seizure, the VEP recovered to
its original waveform.
In patient 5 and 12, VEP was lost during the drilling of burr holes and bone milling. In both
patients, the VEPs recovered after the manipulation.
In patient 11 and 14, VEP waveform disappeared for 20 min after application of 300 mg so-
dium thiopental and for 20 min after application of 5 mg of Dormicum, respectively.
In patient 33, VEP disappeared transiently and neither technical/pharmaceutical issues nor
a surgical maneuver could be identified as a cause. The VEP recovered after 30 min and re-
mained reproducible until the end of surgery.
Table 4. Contingency table of VEP and new visual impairment.
Impaired visual function Preserved visual function Total
Permanent VEP loss 0 (TP) 2 (FP) 2
Unchanged VEP 6 (FN) 54 (TN) 60
Total 6 56 62
doi:10.1371/journal.pone.0120525.t004
Fig 2. Distribution of N75 latencies. The median N75 latency was 87 ms.
doi:10.1371/journal.pone.0120525.g002
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Fig 3. Impaired vision is associated with reduced N75 amplitude. Box plot showing the distribution of the
N75 amplitude in eyes with intact and impaired preoperative visual function. The median N75 amplitude for
the intact vision group (3.92±4.09 μV, range 1.78 to 19.39 μV) was higher than that of the impaired vision
group (2.03±1.16 μV, range 0.68 to 5.03 μV). Mann-Whitney P< 0.001.
doi:10.1371/journal.pone.0120525.g003
Fig 4. Asymmetric vision and VEP in a patient with a lesion in the anterior visual pathway. (A) Anterior
skull base meningioma infiltrating the sinus cavernosus of the sphenoid sinus and the right optic canal
(patient 11). (B)Goldmann perimetry for the left eye: intact visual field. (C)Goldmann perimetry for the right
eye: major visual field defect. (D) VEP of the left eye was highly reproducible throughout surgery (N75 at 74
ms, P100 at 83 ms). (E) In the right eye, the patient’s vision was reduced eye and VEP recording was
not feasible.
doi:10.1371/journal.pone.0120525.g004
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Representative cases
This 54-year-old woman (Patient 11) had a sphenopetroclival meningo-theliomatous meningi-
oma (WHO Grade I) causing a compressive optic neuropathy on her right side (Fig. 4). The
preoperative ophthalmological examination of her right eye showed severely impaired visual
acuity and a major visual field defect, only leaving a small upper nasal quadrant intact. Her left
eye showed normal visual function. The endoscopic approach was adopted for the transsphe-
noidal tumor resection. The left VEP was stable throughout surgery while the right VEP was
flat. At the postoperative neurological examination, the patient showed no new
visual impairment.
The MR image of a 38-year-old woman (Patient 23, Fig. 5) presented a recurrent cranio-
pharyngioma, which progressed in size. The preoperative neurological examination showed a
heteronymous bitemporal hemianopia, accentuated on the left side. The left visual acuity al-
lowed for finger counting only. The endoscopic resection was conducted through a transnasal
approach with a transseptal flap. At the beginning of the surgical procedure, we confirmed the
feasibility of VEP monitoring for both eyes separately. During tumor dissection near the optic
apparatus, the left optic nerve was stretched and the left eye VEP decreased to less than 50% of
the baseline. A warning was issued to the surgeon who consequently altered the surgical strate-
gy. The VEP recovered about 15 min after the warning.
A-47-year-old patient (Patient 28) had a dissecting aneurysm in the right P2 segment with
diameter 20 mm (Fig. 6). A temporo-basal approach from the right side was conducted. The
first clip placement led to a VEP loss after three minutes. Two minutes after the occlusion was
released, the VEP recovered to its original waveform. A second transient occlusion resulted in
the same pattern of VEP loss and recovery. Subsequently, the VEP remained reproducible until
the end of the surgery.
Discussion
Feasibility of intraoperative VEP monitoring depends on preoperative
visual function
In our study, we obtained reproducible VEP in all eyes with intact preoperative visual function.
In eyes with impaired visual function, VEP was obtained in only 29 of 52 (56%) of cases. In im-
paired eyes, the N75 amplitude was significantly lower than in eyes with intact vision. We were
not able to characterize a minimum visual function to predict feasibility of intraoperative VEP.
Detailed ophthalmological documentation preoperatively might help to find optimal criteria
for patient selection. This finding is in line with other studies that indicate that VEP recordings
can only be obtained in patients without severe visual impairments [13, 16, 18, 19]. We did not
encounter any complications with our new device for VEP recording and therefore consider its
use to be safe.
Surgical maneuvers result in immediate VEP loss
The aim of intraoperative VEP monitoring is to alert the surgeon to consequences of surgical
maneuvers. In our series, there were 3 instances, where a surgical maneuver could be related to
immediate VEP loss. In one surgery (case 23), the optic nerve was manipulated and in another
surgery (case 28) the PCA was clipped twice. In all these instances the surgeon was alerted and
subsequently changed the surgical strategy. The VEP recovered within a few minutes (Figs. 5
and 6).There were no new postoperative deficits. In these cases, intraoperative VEP monitoring
provided early detection of damage when it was still in a reversible stage and has influenced the
Clinical Utility and Limitations of Intraoperative Monitoring of VEPs
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surgical strategy. Similar direct correlation has also been described in other studies including
VEP changes during extraaxial manipulation [10, 18] and arterial clipping [16, 19].
Susceptibility of VEP to interfering factors
Anesthesia regiment is known to have strong effects on intraoperative VEP monitoring [4, 10,
20–23] with a main susceptibility to volatile agents. Spontaneous fluctuation of VEP monitor-
ing with TIVA is lower [13–16, 18]. Nevertheless, changes in anesthesia regimen with sodium
thiopental (patient 14) and dormicum (patient 11) interfered with VEP monitoring in
our study.
Fig 5. Transient VEP loss due to manipulation of the optic nerve. (A) Preoperative MR image showing a
recurrent craniopharyngeoma compressing the optic nerve. (B) Initially, VEP responses of the left eye were
reproducible (N75 at 80 ms) in channel Oz/A+. Later in surgery the surgeon manipulated the left optic nerve.
At 15:00, the VEP decrease reached the warning criterion (50%) and a warning was issued to the surgeon
who consequently altered the surgical strategy. At 15:15, VEP recovered about 15min. later with prolonged
latencies. At 15:29, the VEP waveform recovered at the end of the procedure. (C) VEP responses of the right
eye in channel Oz/A+ remained unchanged during the manipulation.
doi:10.1371/journal.pone.0120525.g005
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Additionally, there were cases of transient VEP loss associated with a generalized epileptic
seizure (patient 27), and to bone drilling (patients 5 and 12). In these cases the reason for the
loss was well identifiable. In case 33, the origin remained unknown. In all cases of transient
VEP loss, the visual function remained unchanged. In two eyes of patient 32 and 35 with per-
manent VEP loss, VEPs were feasible at the beginning of the surgery but were lost for unknown
reasons before dura opening. Pharmaceutical and technical issues were excluded. Since the
dura was still closed, no direct surgical maneuver could have caused damage to the visual path-
way. The loss of VEPs did not influence surgical decisions. During the course of surgery, the
waveform did not recover to above the warning criterion. Even though we could not identify a
specific cause for the VEP loss, the point in time of the loss leads us not to expect postoperative
visual deterioration.
Association between intraoperative VEP and postoperative visual
function
Analysis of the contingency table (Table 3) resulted in a specificity of 96% [88–100%] and a
negative predictive value (NPV) of 90% [79–96%]. The positive predictive value (PPV) could
not be calculated because there was no true positive (TP) loss of VEP in our series.
The NPV of 90% suggests that preserved intraoperative VEPs indicate preserved visual
function. Neurological examination was performed in all patients, but they were only con-
firmed ophthalmologically in 28 of 46 (61%) patients preoperatively and in 25 of 46 (54%) pa-
tients postoperatively. While the neurological examination of our patients includes the testing
Fig 6. Transient VEP loss due to aneurysm clipping. (A) Sagittal view. Fusiform dissecting aneurysm
(23mmx20mmx22mm) of the posterior cerebral artery in the P2 segment (Patient 23). Clinically, it manifested
with a light hemiparesis on the left side. (B) Lateral view. (C) Intraoperative screenshot after the placement of
two clips. (D) Initially, VEP responses were reproducible (N75 at 93 ms) in channel O2/A+. The first clip
placement led to a VEP loss after three minutes. Two minutes after the occlusion was released, the VEP
recovered to its original waveform. The VEPs in channel O1/A+ remained unchanged during clipping. (E) A
second transient clip placement resulted in the same pattern of VEP change.
doi:10.1371/journal.pone.0120525.g006
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of visual function, it does not warrant the predictive power of intraoperative VEP as has been
reported by others on the basis of ophthalmologic examination [2, 13, 19].
Stable VEP and new postoperative visual deficit
Intraoperative VEPmonitoring could not detect new postoperative deficits in the posterior visual
pathway in three patients (patients 3, 8 and 15) with parietal or occipital tumors (6 eyes, FN). All
three patients developed homonymous hemianopia postoperatively. In two of these patients, the
preoperative visual function was intact and one patient had a preoperative homonymous quad-
rantanopsia. The intraoperative VEP responses in all three patients appeared stable during resec-
tion of the tumor and during closing of the dura. VEPmonitoring was stopped after dura closure.
In all three patients, there was no intracranial hemorrhage at dura closure. In one patient (patient
8), the postoperativeMR images suggest that a hemorrhage or an ischemic infarction, which oc-
curred after VEP monitoring, may have damaged the posterior visual pathway. However, we can-
not distinguish with certainty whether the postoperative visual deficit was a consequence of the
surgical resection or the postoperative intracranial hemorrhage. As another possibility, the sensi-
tivity of VEP monitoring may have been too low to detect a reduction of VEP amplitude intrao-
peratively. As suggested by a report in the literature, enhanced sensitivity might be achieved by a
lower stimulation amplitude combined with the recording of the electroretinography (ERG) ascer-
taining an efficient light stimulation axis [13]. Since we could not document a true positive (TP)
reduction of visual function in our series, we refrain from predicting postoperative visual outcome
but we focus on intraoperative VEP changes as a result of surgical maneuvers.
Limitations of the study
Postoperative improvements of visual acuity and field could not be detected by VEP record-
ings. In eight eyes of five patients, the postoperative visual function was improved. The intrao-
perative VEP recordings of all eyes remained unchanged throughout the surgical procedure.
The postoperative improvement of the visual impairment (both visual acuity and field) did not
occur instantaneously after surgery, but gradually over several days. Similar findings were re-
ported in other studies suggesting that the affected structures need time to regain their integrity
[13,16]. Therefore, intraoperative VEP monitoring, which is limited to the duration of surgery,
cannot document functional improvement.
In our study, there were nine patients where VEPs were only feasible in the unaffected oph-
thalmic nerve (Table 1; Patients 2, 11, 16, 17, 23, 24, 31, 34 and 35). However, visual deteriora-
tion is most likely to occur on the affected side with some preexisting deficit. Therefore,
preoperative ophthalmologic testing is necessary to predict the clinical utility of intraoperative
VEPs in individual patients.
We could not identify the origin of VEP loss, which occurred in two cases (patient 32 and
35, FP) permanently and in one case (patient 33) transiently. Without electroretinography, de-
viation of the light axis during VEP stimulation could not be excluded. The combination of
intraoperative VEP monitoring with ERG will ascertain retinal light stimulation and might
thereby improve the clinical utility.
Real time monitoring is not yet possible as we need more than 100 seconds to obtain one
waveform. This introduces a delay between a possible damage of the visual pathway, VEP loss
and the surgeon’s reaction.
Conclusions
Satisfactory intraoperative VEPs were feasible in all patients except in those with severe visual
impairment. During resection of lesions in the visual cortex, VEP monitoring could not detect
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new major visual field defects due to injury in the posterior visual pathway. Intraoperative
VEPs were sensitive enough to detect vascular damage during aneurysm clipping and mechani-
cal manipulation of the anterior visual pathway in an early reversible stage. Preservation of
VEPs predicted preserved visual function. Intraoperative VEP monitoring influenced surgical
decisions in selected patients and proved to be a useful supplement to the toolbox of intrao-
perative neurophysiological monitoring.
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